» Authors » B D Naliboff

B D Naliboff

Explore the profile of B D Naliboff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 1408
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Clemens J, Stephens-Shields A, Newcomb C, Rodriguez L, Lai H, Bradley C, et al.
J Urol . 2020 Apr; 204(4):754-759. PMID: 32294397
Purpose: We evaluated and identified baseline factors associated with change in health related quality of life among patients with interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. Materials...
2.
Park S, Naliboff B, Shih W, Presson A, Videlock E, Ju T, et al.
Neurogastroenterol Motil . 2017 Jul; 30(1). PMID: 28718999
Background: Irritable bowel syndrome (IBS) is a stress-sensitive disorder associated with early adverse life events (EALs) and a dysregulated hypothalamic-pituitary-adrenal (HPA) axis. Resilience is the ability to recover and adapt...
3.
Gupta A, Cole S, Labus J, Joshi S, Nguyen T, Kilpatrick L, et al.
Neurogastroenterol Motil . 2017 Feb; 29(6). PMID: 28191693
Background: Distinct gene expression profiles in peripheral blood mononuclear cells (PBMCs) consistent with increased sympathetic nervous system activity have been described in different populations under chronic stress. Neuroinflammatory brain changes,...
4.
Jarrett M, Han C, Cain K, Burr R, Shulman R, Barney P, et al.
Neurogastroenterol Motil . 2016 Mar; 28(7):1094-103. PMID: 26993039
Background: Irritable bowel syndrome (IBS) is a heterogeneous condition with a number of pathophysiological mechanisms that appear to contribute to symptom chronicity. One of these is altered pain sensitivity. Methods:...
5.
Hubbard C, Hong J, Jiang Z, Ebrat B, Suyenobu B, Smith S, et al.
Neurogastroenterol Motil . 2015 Jun; 27(9):1282-94. PMID: 26087779
Background: Increased attention to gastrointestinal (GI) symptoms and disease-specific contexts may play an important role in the enhanced perception of visceral stimuli frequently reported in patients with irritable bowel syndrome...
6.
Cheng P, Shih W, Alberto M, Presson A, Licudine A, Mayer E, et al.
Neurogastroenterol Motil . 2013 Jul; 25(10):e650-9. PMID: 23822743
Background: Previous studies reported altered autonomic nervous system (ANS) responses in irritable bowel syndrome (IBS) at baseline and to colonic balloon distension. This study examined heart rate variability (HRV) and...
7.
Labus J, Gupta A, Gill H, Posserud I, Mayer M, Raeen H, et al.
Aliment Pharmacol Ther . 2012 Dec; 37(3):304-15. PMID: 23205588
Background: Evidence supports the effectiveness of cognitive behavioural approaches in improving the symptoms of the irritable bowel syndrome (IBS). Duration, cost and resistance of many patients towards a psychological therapy...
8.
Kilpatrick L, Ornitz E, Ibrahimovic H, Treanor M, Craske M, Nazarian M, et al.
Biol Psychol . 2010 Mar; 84(2):272-8. PMID: 20193731
Alterations in central networks involved in the regulation of arousal, attention, and cognition may be critical for irritable bowel syndrome (IBS) symptom maintenance and exacerbation. Differential sensitivities in these networks...
9.
Jarcho J, Chang L, Berman M, Suyenobu B, Naliboff B, Lieberman M, et al.
Aliment Pharmacol Ther . 2008 Dec; 28(3):344-52. PMID: 19086332
Background: Symptom improvement in irritable bowel syndrome (IBS) treatment trials varies widely, with only 50-70% of patients qualifying as responders. Factors predicting treatment responsiveness are not known, although we have...
10.
Chang L, Sundaresh S, Elliott J, Anton P, Baldi P, Licudine A, et al.
Neurogastroenterol Motil . 2008 Aug; 21(2):149-59. PMID: 18684212
Enhanced stress responsiveness has been implicated as a potential mechanism contributing to the pathophysiology of irritable bowel syndrome (IBS), and should be reflected in altered function of the hypothalamic-pituitary-adrenal (HPA)...